Severe infections following treatment for childhood cancer: a report from CYP-C

References

• Cheng S, Pole JD, Sung L. Early deaths in pediatric acute leukemia: a population-based study. Leuk Lymphoma. 2014;55(7):1518–1522.
   PubMed Web of Science ®Google Scholar
• Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532–3539.
   PubMed Web of Science ®Google Scholar
• Dix D, Cellot S, Price V, et al. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group. Clin Infect Dis. 2012;55(12):1608–1614.
   PubMed Web of Science ®Google Scholar
• Afzal S, Ethier MC, Dupuis LL, et al. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia. Pediatr Infect Dis J. 2009;28(12):1064–1068.
   PubMed Web of Science ®Google Scholar
• Pelland-Marcotte MC, Hwee J, Pole JD, et al. Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature. Leuk Lymphoma. 2019;60(9):2104–2114.
   PubMed Web of Science ®Google Scholar
• Pelland-Marcotte MC, Pole JD, Hwee J, et al. Long-term risk of infections following treatment for childhood leukemia: a population-based cohort study using administrative health data. J Clin Oncol. 2019;37(29):2651–2660.
   PubMed Web of Science ®Google Scholar
• Perkins JL, Chen Y, Harris A, et al., Childhood Cancer Survivor Study. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014;120(16):2514–2521.
   PubMed Web of Science ®Google Scholar
• Rugbjerg K, Olsen JH. Long-term risk of hospitalization for somatic diseases in survivors of adolescent or young adult cancer. JAMA Oncol. 2016;2(2):193–200.
   PubMed Web of Science ®Google Scholar
• Lorenzi MF, Xie L, Rogers PC, et al. Hospital-related morbidity among childhood cancer survivors in British Columbia, Canada: report of the childhood, adolescent, young adult cancer survivors (CAYACS) program. Int J Cancer. 2011;128(7):1624–1631.
   PubMed Web of Science ®Google Scholar
• Suzuki M. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission. Jpn J Clin Oncol. 1984;14(1):31–40.
   PubMed Web of Science ®Google Scholar
• Kristinsson VH, Kristinsson JR, Jonmundsson GK, et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol. 2001;18(3):167–172.
   PubMed Web of Science ®Google Scholar
• van Tilburg CM, Bierings MB, Berbers GA, et al. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases. Pediatr Blood Cancer. 2012;58(5):701–707.
   PubMed Web of Science ®Google Scholar
• Reinhardt D, Houliara K, Pekrun A, et al. Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer. Scand J Infect Dis. 2003;35(11–12):851–857.
   PubMed Web of Science ®Google Scholar
• Wiegering V, Frank J, Freudenberg S, et al. Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia. Leuk Lymphoma. 2014;55(4):870–875.
   PubMed Web of Science ®Google Scholar
• Mueller BA, Doody DR, Weiss NS, et al. Hospitalization and mortality among pediatric cancer survivors: a population-based study. Cancer Causes Control. 2018;29(11):1047–1057.
   PubMed Web of Science ®Google Scholar
• Steliarova-Foucher E, Stiller C, Lacour B, et al. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–1467.
   PubMed Web of Science ®Google Scholar
• Sung L, Aplenc R, Alonzo TA, et al. Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group. Blood. 2013;121(18):3573–3577.
   PubMed Web of Science ®Google Scholar
• Larsen EC, Devidas M, Chen S, et al. Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children's oncology group study AALL0232. J Clin Oncol. 2016;34(20):2380–2388.
   PubMed Web of Science ®Google Scholar
• Cooper TM, Franklin J, Gerbing RB, et al. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group. Cancer. 2012;118(3):761–769.
   PubMed Web of Science ®Google Scholar
• Greenberg ML, Barr RD, DiMonte B, et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003;105(1):88–91.
   PubMed Web of Science ®Google Scholar
• Pole JD, Barber R, Bergeron RE, et al. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study. BMC Cancer. 2017;17(1):402.
   PubMedGoogle Scholar
• Cancer Therapy Evaluation Program. Common terminology criteria for adverse events (CTCAE) v4.0 2010 [cited 2019 Sept 19]. Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40.
   Google Scholar
• Pong RW, DesMeules M, Heng D, et al. Patterns of health services utilization in rural Canada. Chronic Dis Inj Can. 2011;31:1–36.
   PubMedGoogle Scholar
• Dietitians of Canada, Canadian Paediatric Society, The College of Family Physicians of Canada, et al. Promoting optimal monitoring of child growth in Canada: using the new WHO growth charts. Can J Diet Pract Res. 2010;71(1):e1–e3.
   PubMedGoogle Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
   Web of Science ®Google Scholar
• Gruber C, Keil T, Kulig M, et al. History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol. 2008;19(6):505–512.
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Brand R, Frassoni F, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36(9):757–769.
   PubMed Web of Science ®Google Scholar
• Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164(1):9–16.
   PubMed Web of Science ®Google Scholar
• Aytac S, Yalcin SS, Cetin M, et al. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2010;27(5):333–343.
   PubMed Web of Science ®Google Scholar
• Koskenvuo M, Ekman I, Saha E, et al. Immunological reconstitution in children after completing conventional chemotherapy of acute lymphoblastic leukemia is marked by impaired B-cell compartment. Pediatr Blood Cancer. 2016;63(9):1653–1656.
   PubMed Web of Science ®Google Scholar
• Ek T, Mellander L, Hahn-Zoric M, et al. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia – implications for vaccination strategies. Acta Paediatr. 2006;95(6):701–706.
   PubMed Web of Science ®Google Scholar
• Ek T, Mellander L, Hahn-Zoric M, et al. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol. 2004;26(11):727–734.
   PubMed Web of Science ®Google Scholar
• Kosmidis S, Baka M, Bouhoutsou D, et al. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL. Pediatr Blood Cancer. 2008;50(3):528–532.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Schubert R, Behl M, et al. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia. Br J Haematol. 2009;147(5):700–705.
   PubMed Web of Science ®Google Scholar
• Perkins JL, Harris A, Pozos TC. Immune dysfunction after completion of childhood leukemia therapy. J Pediatr Hematol Oncol. 2017;39(1):1–5.
   PubMed Web of Science ®Google Scholar
• Azuma E, Nagai M, Qi J, et al. CD4+ T‐Lymphocytopenia in long‐term survivors following intensive chemotherapy in childhood cancers. Med Pediatr Oncol. 1998;30(1):40–45.
   PubMedGoogle Scholar
• Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol. 1998;20(5):451–457.
   PubMed Web of Science ®Google Scholar
• Januszkiewicz-Lewandowska D, Gowin E, Bocian J, et al. Vaccine-derived immunity in children with cancer-analysis of anti-tetanus and anti-diphtheria antibodies changes after completion of antineoplastic therapy. Pediatr Blood Cancer. 2015;62(12):2108–2113.
   PubMed Web of Science ®Google Scholar
• Bochennek K, Allwinn R, Langer R, et al. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine. 2014;32(27):3357–3361.
   PubMed Web of Science ®Google Scholar
• Toubert A, Glauzy S, Douay C, et al. Immune reconstitution after allogeneic HSCT. In: Carreras E, Dufour C, Mohty M, editors. EBMT handbook: hematopoietic stem cell transplantation. Paris: European School of Haematology; 2012. p. 234–247.
   Google Scholar
• Haining NW, Duncan CN, El-Haddad A, et al. Principles of bone marrow and stem cell transplantation. In: Orkin SH, Nathan DG, Ginsburg D, et al. editors. Nathan and Oski's hematology of infancy and childhood. Vol. 1. 8 ed. Amsterdam, The Netherlands: Elsevier Health Sciences; 2015. p. 254–290.
   Google Scholar
• Weil BR, Madenci AL, Liu Q, et al. Late infection-related mortality in Asplenic survivors of childhood cancer: a report from the childhood cancer survivor study. JCO. 2018;36(16):1571–1578.
   PubMed Web of Science ®Google Scholar
• Kvestad E, Kvaerner KJ, Roysamb E, et al. The reliability of self-reported childhood otitis media by adults. Int J Pediatr Otorhinolaryngol. 2006;70(4):597–602.
   PubMed Web of Science ®Google Scholar
• Demoré B, Le Govic D, Thilly N, et al. Reliability of self-reported recent antibiotic use among the general population: a cross-sectional study. Clin Microbiol Infect. 2017;23(7):486.e487–486.e412.
   Web of Science ®Google Scholar
• Simpson J, Smith A, Ansell P, et al. Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer 2007;43(16):2396–2403.
   PubMed Web of Science ®Google Scholar